Evidence to support the widespread use of psychedelics to treat mental health conditions such as depression is lacking, according to politicians and representatives of peak health bodies interviewed for a research paper published on Wednesday.
Researchers from Monash University in Melbourne conducted in-depth interviews with senior experts from a range of organisations involved in psychedelic drug law reform, clinical use or regulation.
